Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
GlobeNewswire
Phoenix, AZ, May 23, 2024 (GLOBE NEWSWIRE) --
· Results will be presented at American Society of Clinical Oncology..